DK1154792T3 - Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans - Google Patents

Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans

Info

Publication number: DK1154792T3
Authority: DK; Denmark
Prior art keywords: sub; adjuvant; fatty acids; monoglycerides; vaccine formulation
Prior art date: 1999-02-12

Application number

DK00906305T

Other languages

English (en)

Inventor

Ulf Schroeder

Stefan Svenson

Original Assignee

Eurocine Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-12

Filing date

2000-02-09

Publication date

2007-02-12

2000-02-09 Application filed by Eurocine Ab filed Critical Eurocine Ab

2007-02-12 Application granted granted Critical

2007-02-12 Publication of DK1154792T3 publication Critical patent/DK1154792T3/da

Links

239000000203 mixture Substances 0.000 title abstract 3
239000002671 adjuvant Substances 0.000 title abstract 2
235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
229930195729 fatty acid Natural products 0.000 title abstract 2
239000000194 fatty acid Substances 0.000 title abstract 2
150000004665 fatty acids Chemical class 0.000 title abstract 2
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229960002109 tuberculosis vaccine Drugs 0.000 title 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 2
201000008827 tuberculosis Diseases 0.000 abstract 2
241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Toxicology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00906305T 1999-02-12 2000-02-09 Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans DK1154792T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9900495A SE9900495D0 (sv)	1999-02-12	1999-02-12	Vaccine composition
PCT/EP2000/001046 WO2000047225A2 (en)	1999-02-12	2000-02-09	Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant

Publications (1)

Publication Number	Publication Date
DK1154792T3 true DK1154792T3 (da)	2007-02-12

Family

ID=20414469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00906305T DK1154792T3 (da)	1999-02-12	2000-02-09	Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans

Country Status (10)

Country	Link
US (1)	US6936260B1 (da)
EP (1)	EP1154792B1 (da)
AT (1)	ATE342065T1 (da)
AU (1)	AU769390B2 (da)
DE (1)	DE60031243T2 (da)
DK (1)	DK1154792T3 (da)
ES (1)	ES2275495T3 (da)
NZ (1)	NZ513130A (da)
SE (1)	SE9900495D0 (da)
WO (1)	WO2000047225A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPR030800A0 (en) *	2000-09-22	2000-10-12	Pharmalink International Limited	Immunomodulatory preparation
CN1612753A (zh) *	2001-11-14	2005-05-04	诺瓦瓦克斯有限公司	分枝杆菌疫苗
PT1461054E (pt) *	2001-12-11	2010-08-09	Pasteur Institut	Preparações de bactérias gram positivas para o tratamento de doenças que implicam uma desregulação imunitária
CU23476A1 (es) *	2004-01-29	2009-12-17	Ct Ingenieria Genetica Biotech	Formulación adyuvante conteniendo una emulsión oleosa con aceite de jojoba
EP1843787B1 (en) *	2005-01-28	2011-11-02	North-West University	Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
DK2144626T3 (da)	2007-04-12	2015-02-09	Mico Bio Inc	Tuberkulosevaccine og fremgangsmåde til anvendelse af samme
CN102441162B (zh) *	2010-10-04	2018-07-24	免疫产品美国股份有限公司	结核病的治疗和预防
WO2012145491A2 (en) *	2011-04-20	2012-10-26	Jason Fisher	Composition and method for enhancing an immune response
EP2620159A1 (en) *	2012-01-24	2013-07-31	Institut Pasteur	Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria
WO2018006939A1 (en)	2016-07-05	2018-01-11	Universidad De Zaragoza	Inactivated tuberculosis vaccine
WO2020115161A1 (en)	2018-12-04	2020-06-11	Sabiotec Spin-Off Sl	Immunostimulant for use against pathogens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0832638B2 (ja) *	1989-05-25	1996-03-29	カイロンコーポレイション	サブミクロン油滴乳剤を含んで成るアジュバント製剤
WO1993006921A1 (en)	1991-10-04	1993-04-15	Gs Biochem Ab	Particles, method of preparing said particles and uses thereof
DK17093D0 (da)	1993-02-15	1993-02-15	Lyfjathroun H F	Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
ATE318147T1 (de) *	1996-03-25	2006-03-15	Medarex Inc	Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
SE9602280D0 (sv)	1996-06-10	1996-06-10	Pharmatrix Ab	Immunstimulerande lipidformulering

1999
- 1999-02-12 SE SE9900495A patent/SE9900495D0/xx unknown
2000
- 2000-02-09 DK DK00906305T patent/DK1154792T3/da active
- 2000-02-09 AT AT00906305T patent/ATE342065T1/de not_active IP Right Cessation
- 2000-02-09 EP EP00906305A patent/EP1154792B1/en not_active Expired - Lifetime
- 2000-02-09 WO PCT/EP2000/001046 patent/WO2000047225A2/en not_active Ceased
- 2000-02-09 DE DE60031243T patent/DE60031243T2/de not_active Expired - Lifetime
- 2000-02-09 ES ES00906305T patent/ES2275495T3/es not_active Expired - Lifetime
- 2000-02-09 US US09/926,001 patent/US6936260B1/en not_active Expired - Fee Related
- 2000-02-09 AU AU28035/00A patent/AU769390B2/en not_active Ceased
- 2000-02-09 NZ NZ513130A patent/NZ513130A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE342065T1 (de)	2006-11-15
ES2275495T3 (es)	2007-06-16
NZ513130A (en)	2003-01-31
AU2803500A (en)	2000-08-29
DE60031243D1 (de)	2006-11-23
DE60031243T2 (de)	2007-05-24
SE9900495D0 (sv)	1999-02-12
US6936260B1 (en)	2005-08-30
AU769390B2 (en)	2004-01-22
EP1154792B1 (en)	2006-10-11
WO2000047225A2 (en)	2000-08-17
EP1154792A2 (en)	2001-11-21
WO2000047225A3 (en)	2000-12-14

Similar Documents

Publication	Publication Date	Title
DK0777490T3 (da)	2006-09-18	Mutant-enterotoxin, som er effektivt som et ikke-toksisk oralt adjuvans
NO20002741L (no)	2000-05-26	Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
DK1154792T3 (da)	2007-02-12	Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans
MD1586G2 (ro)	2001-10-31	Inducere a unui răspuns citotoxic T-limfocitar
NO20052010L (no)	2005-06-24	Immunogen sammensetning
EP1955709A3 (en)	2008-08-20	Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines
NO976060L (no)	1998-02-17	Vaksiner mot hepatitt C
PT865297E (pt)	2003-03-31	Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
BRPI0000126B8 (pt)	2022-05-10	composição de vacina, composição adjuvante e método de produção de uma composição de vacina
EP2275121A3 (en)	2011-04-13	Protein-based streptococcus pneumoniae vaccines
CA2258217A1 (en)	1997-12-18	Substituted cyclopentane compounds useful as neuraminidase inhibitors
ATE284710T1 (de)	2005-01-15	Adjuvans für vitale impfstoffe
DK0745388T3 (da)	2002-12-02	Mammalt vaccinepræparat omfattende squalen eller squalan, phospholipid og et overfladeaktivt stof som adjuvans
GB9306731D0 (en)	1993-05-26	Vaccines
BR0111834A (pt)	2003-07-08	Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
SE9602280D0 (sv)	1996-06-10	Immunstimulerande lipidformulering
DK1150713T3 (da)	2005-08-29	Vaccineformulering der omfatter monoglycerider eller fedtsyrer som adjuvans
IL116010A0 (en)	1996-01-31	Immunogenic compositions
BRPI0414073A (pt)	2006-10-24	método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
BR9713296A (pt)	1999-10-26	Processo para a preparação de derivados 2-amino-2-imidazolino, guanidino, e 2-amino-3,4,5,6-tetrahidro-pirimidina
ES2136965T3 (es)	1999-12-01	Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
KR910002455A (ko)	1991-02-25	아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
ITTO20001044A0 (it)	2000-11-07	Procedimento e impianto per il trattamento di prodotti di uovo e simili, destinati all'uso alimentare.
KR890701118A (ko)	1989-12-19	혈소판 감소증 예방 및 치료제
SU1615917A1 (ru)	1995-11-10	Адъювант